Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials

Silvio Danese, Séverine Vermeire, Wen Zhou, Aileen L. Pangan, Jesse Siffledeen, Susan Greenbloom, Xavier Hébuterne, Geert D’Haens, Hiroshi Nakase, Julián Panés, Peter Higgins, Pascal Juillerat, James O. Lindsay, Edward V. Loftus, William J. Sandborn, Walter Reinisch, Minhu Chen, Yuri Sánchez González, Bidan Huang, Wangang Xie, John Liu, Michael Weinreich, Remo Panaccione